ENSG:NGS-The Ensign Group Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 123.69

Change

+2.85 (+2.36)%

Market Cap

USD 1.10B

Volume

1.21M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ensign Group Inc offers skilled nursing & rehabilitative care services in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas & Washington.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 84.15B
THC Tenet Healthcare Corporation

N/A

USD 13.29B
UHS Universal Health Services Inc

N/A

USD 12.78B
DVA DaVita HealthCare Partners Inc

N/A

USD 12.08B
FMS Fresenius Medical Care Corpora..

N/A

USD 11.24B
EHC Encompass Health Corp

N/A

USD 8.59B
CHE Chemed Corp

N/A

USD 8.16B
SEM Select Medical Holdings

N/A

USD 4.47B
AGL agilon health Inc

N/A

USD 2.69B
AMN AMN Healthcare Services Inc

N/A

USD 2.02B

ETFs Containing ENSG

OSCV 2.94 % 0.79 %

N/A

N/A
XHS SPDR® S&P Health Care Se.. 2.21 % 0.35 %

N/A

USD 0.08B
VIOG Vanguard S&P Small-Cap 60.. 1.16 % 0.20 %

N/A

USD 0.85B
SLYG SPDR® S&P 600 Small Cap .. 1.15 % 0.15 %

N/A

USD 3.19B
XSLV Invesco S&P SmallCap Low .. 1.08 % 0.25 %

N/A

USD 0.32B
ESIX SPDR S&P SmallCap 600 ESG.. 0.84 % 0.00 %

N/A

USD 5.05M
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.84 % 0.00 %

N/A

USD 0.12B
MWON:XETRA Amundi S&P SmallCap 600 E.. 0.84 % 0.00 %

N/A

USD 0.12B
USASUS:SW Amundi S&P SmallCap 600 E.. 0.84 % 0.00 %

N/A

USD 0.12B
ZSML:CA BMO S&P US Small Cap Inde.. 0.60 % 0.00 %

N/A

N/A
ZSML-F:CA BMO S&P US Small Cap Inde.. 0.60 % 0.00 %

N/A

CAD 5.46M
ZSML-U:CA BMO S&P US Small Cap Inde.. 0.60 % 0.00 %

N/A

N/A
SPSM SPDR® Portfolio S&P 600 .. 0.60 % 0.06 %

N/A

USD 10.17B
IDP6:SW iShares S&P SmallCap 600 .. 0.59 % 0.00 %

N/A

USD 1.65B
IUS3:F iShares S&P Small Cap 600.. 0.57 % 0.00 %

N/A

USD 1.75B
VIOO Vanguard S&P Small-Cap 60.. 0.57 % 0.15 %

N/A

USD 2.58B
SAA ProShares Ultra SmallCap6.. 0.46 % 0.95 %

N/A

USD 0.03B
IJR iShares Core S&P Small-Ca.. 0.00 % 0.07 %

N/A

USD 76.42B
IJT iShares S&P Small-Cap 600.. 0.00 % 0.25 %

N/A

USD 5.76B
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

N/A

USD 0.20B
OLD 0.00 % 0.50 %

N/A

N/A
KSCD 0.00 % 0.00 %

N/A

N/A
SLY 0.00 % 0.15 %

N/A

N/A
IDP6:LSE iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

USD 1.65B
ISP6:LSE iShares III Public Limite.. 0.00 % 0.00 %

N/A

USD 1.65B
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

USD 1.59B
SMLE DBX ETF Trust - S&P Small.. 0.00 % 0.00 %

N/A

USD 1.36M
DFAS Dimensional U.S. Small Ca.. 0.00 % 0.00 %

N/A

USD 7.91B
QVMS Invesco Exchange-Traded F.. 0.00 % 0.00 %

N/A

USD 0.18B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.23% 50% F 78% C+
Dividend Return 0.11% 8% B- 2% F
Total Return 10.34% 50% F 74% C
Trailing 12 Months  
Capital Gain 29.57% 77% C+ 88% B+
Dividend Return 0.25% 8% B- 3% F
Total Return 29.82% 77% C+ 86% B+
Trailing 5 Years  
Capital Gain 117.30% 79% B- 89% A-
Dividend Return 1.91% 18% F 6% D-
Total Return 119.22% 79% B- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 29.67% 88% B+ 90% A-
Dividend Return 29.99% 85% B 89% A-
Total Return 0.32% 17% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 39.83% 50% F 24% F
Risk Adjusted Return 75.29% 92% A 91% A-
Market Capitalization 1.10B 75% C 80% B-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.30 17% 21%
Price/Book Ratio 4.55 36% 19%
Price / Cash Flow Ratio 18.32 14% 18%
Price/Free Cash Flow Ratio 23.03 11% 10%
Management Effectiveness  
Return on Equity 15.08% 60% 73%
Return on Invested Capital 12.65% 69% 74%
Return on Assets 4.02% 54% 64%
Debt to Equity Ratio 9.75% 77% 87%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.